ICAM1-DM1 ADC (Boston Children's Hospital)

N/A

Report date: 2025/03/20 15:29:49

Base Information

Drug NameICAM1-DM1 ADC (Boston Children's Hospital)

Drug Alias Nameanti- ICAM1 antibody-DM1 conjugate (Boston Children's Hospital)anti-ICAM1 antibody-drug conjugate (Boston Children's Hospital)anti-ICAM1-SMCC-DM1 (Boston Children's Hospital)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionIntercellular adhesion molecule-1 modulators

TargetsIntercellular adhesion molecule-1

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe Children's Hospital Corp

China Registration ClassN/A

Develop Information

Active CompaniesThe Children's Hospital Corp

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A